Fig. 5From: Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancerDistribution of the methylation status in tumor (T), tumor-adjacent (A) and tumor-distant (D) tissues. Patients have only been included if the methylation status in the tumor tissue was ≥ LOQ. Straight line: median, dashed line: arithmetic mean. LOQ limit of quantificationBack to article page